Slow Gait, Subjective Cognitive Decline and Motoric Cognitive RISK Syndrome: Prevalence and Associated Factors in

Reshma A Merchant1, J Goh, Y H Chan

  • 1Associate Professor Reshma Merchant, Division of Geriatric Medicine, Department of Medicine, National University Hospital, Singapore 119228, Email: reshmaa@nuhs.edu.sg, Telephone number: +65 6779 5555, ORCID iD: 0000-0002-9032-0184.

Abstract

Insights

Motoric Cognitive Risk Syndrome (MCR) and slow gait speed (SG) are linked to cognitive decline in older adults. Gait speed is a crucial indicator for negative health outcomes.

Area of Science:

  • Gerontology
  • Neurology
  • Public Health

Background:

  • Motoric Cognitive Risk Syndrome (MCR), slow gait speed (SG), and subjective cognitive decline (SCD) are recognized early indicators of dementia.
  • MCR is associated with a threefold increased risk of future dementia, and SG can precede cognitive impairment.

Purpose of the Study:

  • To determine the prevalence and demographics of MCR, SG alone (SG-A), and SCD alone (SCD-A) in community-dwelling older adults.
  • To investigate the associations of MCR, SG-A, and SCD-A with physical, functional, cognitive, and psychosocial factors.

Main Methods:

  • 509 participants were classified into four groups based on the presence of SG and/or SCD.
  • Multinomial logistic regression analysis was employed to identify factors associated with SG-A, SCD-A, and MCR.

Main Results:

  • Prevalence rates were MCR: 13.6%, SG-A: 13.0%, and SCD-A: 35.0%. MCR prevalence doubled per decade in females.
  • MCR and SG-A groups were older, had higher BMI, lower education, poorer cognition (especially non-memory domains), lower grip strength, and lower physical performance scores.
  • MCR was linked to higher prevalence of pain, depression, frailty, social isolation, and ADL impairment. SG-A was associated with increased multi-morbidity and diabetes.

Conclusions:

  • Both MCR and SG-A are associated with global cognitive decline, particularly in non-memory domains, and reduced functional scores.
  • Gait speed is a significant predictor of adverse outcomes and should be considered a vital sign.
  • Further research is needed to explore dementia conversion across ethnic groups and the impact of interventions on physical measures and disability.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
527
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
371
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
100